Commit To Buy Adamas Pharmaceuticals At $12.50, Earn 12.5% Annualized Using Options
October 26, 2016 at 11:53 AM EDT
Investors eyeing a purchase of Adamas Pharmaceuticals Inc (ADMS) stock, but cautious about paying the going market price of $14.56/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the June 2017 put at the $12.50 strike, which has a bid at the time of this writing of $1.00..